Biotech entity
All 1 tracked stories fall under one category: fda-approval. Network for Hope is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 6 original sources on average. We currently track 1 Biotech story that mention CMS (Centers for Medicare & Medicaid Services), all published on August 6, 2026.
Last mentioned: Aug 6, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: fda-approval. Network for Hope is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 6 original sources on average. We currently track 1 Biotech story that mention CMS (Centers for Medicare & Medicaid Services), all published on August 6, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering CMS (Centers for Medicare & Medicaid Services). Shared-story counts are live from our verified record — not editorial picks.
The planned shutdown of Network for Hope over pressure to retrieve organs from a living patient spotlights the fragile ethical foundation of the human tissue supply chain. Biotech companies reliant on donated organs for research and development face new regulatory uncertainty.
CMS (Centers for Medicare & Medicaid Services) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
